Drugs that contain Ropinirole Hydrochloride
1. Requip Xl patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8303986 | GLAXOSMITHKLINE LLC | Hydrophilic/lipophilic polymeric matrix dosage formulation |
Apr, 2021
(3 years ago) | |
| US7927624 | GLAXOSMITHKLINE LLC | Hydrophilic/lipophilic polymeric matrix dosage formulation |
Dec, 2021
(2 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-203) | Mar 23, 2020 |
Market Authorisation Date: 13 June, 2008
Treatment: A process for treating a patient suffering from parkinson's syndrome and in need of treatment
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of REQUIP XL before it's drug patent expiration?
More Information on Dosage
REQUIP XL family patents
